摘要
目的比较雷贝拉唑与奥美拉唑三联疗法在消化性溃疡治疗中的临床效果。方法本次研究选取我院2009年2月至2011年11月间56例消化性溃疡患者,随机分成雷贝拉唑组和奥美拉唑组。雷贝拉唑组的患者使用雷贝拉唑药物进行治疗,奥美拉唑组的患者使用奥美拉唑药物进行治疗,对相关情况进行了比较分析。结果两组患者腹痛程度均得到缓解,雷贝拉唑组效果优于奥美拉唑组;雷贝拉唑组治疗疗效良好的达到了71.4%,奥美拉唑组治疗疗效良好的达到57.1%,P均<0.05,差异有统计学意义。结论雷贝拉唑与奥美拉唑三联疗法对于HP都能起到有效的抑制作用,但是雷贝拉唑的效果更加明显,值得在临床中进行推广和应用。
Objective To compare the clinical effect of rabeprazole triple therapy with omeprazole in the treatment of peptic ulcer. Methods 56 cases of peptic ulcer patients from February 2009 to November 2011 in our hospital were randomly divided into Rabeprazole group and omeprazole group. Rabeprazole group was treated with rabeprazole drugs, omeprazole group was treated with drug treatment. The relevant circumstances were taken for comparative analysis. Results The two groups were eased in the abdominal [gain. The rabeprazole group was better than omeprazole group. The rabeprazole therapy group achieved 71.4%, and the well-omeprazole therapy was up to 57.1%, P〈0.05, the difference was statistically significant. Conclusion Rabeprazole versus omeprazole triple therapy can play an effective inhibition for the HP, but the effect of rabeprazole is more obvious, it is worth of promotion and clinical applications.
出处
《中国医药指南》
2012年第14期25-26,共2页
Guide of China Medicine
